Review article · 2015 · Open access

Immunity, inflammation, and cancer: an eternal fight between good and evil

Shabnam Shalapour, Michael Karin

Journal of Clinical Investigation, 125(9), 3347–3355 · Published 31 August 2015 · DOI 10.1172/jci80007

Free PDFView at the publisherCite this paper

In brief

“Immunity, inflammation, and cancer: an eternal fight between good and evil” is a 2015 review article by Shabnam Shalapour and Michael Karin, published in Journal of Clinical Investigation. OpenAlex counts 722 citations as of 15 November 2026, which puts it in the top 3% of works published in 2015 by citations. It is open access: the full text is free to read at Journal of Clinical Investigation.

Citations
722
Most cited in
2020 (96)
Field-weighted impact
6.06
References
148
Authors
2

Abstract

Cancer development and its response to therapy are strongly influenced by innate and adaptive immunity, which either promote or attenuate tumorigenesis and can have opposing effects on therapeutic outcome. Chronic inflammation promotes tumor development, progression, and metastatic dissemination, as well as treatment resistance. However, cancer development and malignant progression are also associated with accumulation of genetic alterations and loss of normal regulatory processes, which cause expression of tumor-specific antigens and tumor-associated antigens (TAAs) that can activate antitumor immune responses. Although signals that trigger acute inflammatory reactions often stimulate dendritic cell maturation and antigen presentation, chronic inflammation can be immunosuppressive. This antagonism between inflammation and immunity also affects the outcome of cancer treatment and needs to be considered when designing new therapeutic approaches.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shalapour, S., & Karin, M. (2015). Immunity, inflammation, and cancer: an eternal fight between good and evil. Journal of Clinical Investigation, 125(9), 3347–3355. https://doi.org/10.1172/jci80007

MLA 9

Shalapour, Shabnam, and Michael Karin. “Immunity, inflammation, and cancer: an eternal fight between good and evil.” Journal of Clinical Investigation, vol. 125, no. 9, 2015, pp. 3347–3355. https://doi.org/10.1172/jci80007.

Chicago

Shalapour, Shabnam and Michael Karin. 2015. “Immunity, inflammation, and cancer: an eternal fight between good and evil.” Journal of Clinical Investigation 125 (9): 3347–3355. https://doi.org/10.1172/jci80007.

Harvard

Shalapour, S. and Karin, M. (2015) ‘Immunity, inflammation, and cancer: an eternal fight between good and evil’, Journal of Clinical Investigation, 125(9), pp. 3347–3355. doi:10.1172/jci80007.

IEEE

S. Shalapour and M. Karin, “Immunity, inflammation, and cancer: an eternal fight between good and evil,” Journal of Clinical Investigation, vol. 125, no. 9, pp. 3347–3355, 2015, doi: 10.1172/jci80007.

BibTeX

@article{shalapour2015immunity,
  title     = {{Immunity, inflammation, and cancer: an eternal fight between good and evil}},
  author    = {Shalapour, Shabnam and Karin, Michael},
  journal   = {Journal of Clinical Investigation},
  year      = {2015},
  volume    = {125},
  number    = {9},
  pages     = {3347--3355},
  doi       = {10.1172/jci80007},
  url       = {https://doi.org/10.1172/jci80007}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20176767
20188888
20199494
20209696
20218282
20226565
20235353
20244646
20255252
20263434

Its field-weighted citation impact is 6.06: it has been cited 6.06 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer

  • tumor immunology
  • chronic inflammation
  • carcinogenesis
  • tumor progression
  • metastasis
  • treatment resistance
  • tumor-associated antigens
  • tumor-specific antigens

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Shalapour, S., & Karin, M. (2015). Immunity, inflammation, and cancer: an eternal fight between good and evil. Journal of Clinical Investigation, 125(9), 3347–3355. https://doi.org/10.1172/jci80007

How many times has this paper been cited?

722 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Journal of Clinical Investigation.

Who wrote this paper?

Shabnam Shalapour, Michael Karin.

What is the DOI of this paper?

10.1172/jci80007. The permanent link is https://doi.org/10.1172/jci80007.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.